Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening

Neurology

Volumn 64, Issue 6, 2005, Pages 1076-1077

  Verstappen, C C P ^a   Koeppen, S ^b   Heimans, J J ^a   Huijgens, P C ^a   Scheulen, M E ^b   Strumberg, D ^b   Kiburg, B ^a   Postma, T J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VINCRISTINE;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; GRIP STRENGTH; HEMIFACIAL ATROPHY; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MUSCLE STRENGTH; NEUROLOGIC DISEASE; NEUROTOXICITY; PAIN; PARESTHESIA; PERIPHERAL NEUROPATHY; PHYSICAL CAPACITY; PRIORITY JOURNAL;

EID: 15244346675     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000154642.45474.28     Document Type: Article

References (10)

1. Bradley WG, Lassman LP, Pearce GW, Walton JN. The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci 1970;10:107-131.
2. Casey EB, Jellife AM, Le Quesne PM, Millett YL. Vincristine neuropathy. Clinical and electrophysiological observations. Brain 1973;96:69-86.
3. Holland JF, Scharlau C, Gailani S, et al. Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res 1973;33: 1258-1264.
4. Koeppen S, Verstappen CC, Korte R, et al. Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma. J Cancer Res Clin Oncol 2004;130:153-160.
5. Postma TJ, Vermorken JB, Liefting AJ, Pinedo HM, Heimans JJ. Paclitaxel-induced neuropathy. Ann Oncol 1995;6:489-494.
6. Sandler SG, Tobin W, Henderson ES. Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology 1969;19:367-374.
7. Haim N, Epelbaum R, Ben Shahar M, Yarnitsky D, Simri W, Robinson E. Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas. Cancer 1994;73:2515-2519.
8. Siegal T, Haim N. Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps. Cancer 1990;66:1117-1123.
9. Glantz MJ, Choy H, Kearns CM, et al. Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas. J Clin Oncol 1996;14:600-609.
10. Hilkens PH, Verweij J, Stoter G, Vecht CJ, van Putten WL, van den Bent MJ. Peripheral neurotoxicity induced by docetaxel. Neurology 1996;46:104-108.